CYTEK BIOSCIENCES INC. - COMMON STOCK

Cytek Biosciences Reports Third Quarter 2023 Financial Results

07 11 2023 16:05:01 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023

19 10 2023 16:05:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters

27 9 2023 09:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

20 9 2023 16:15:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe

20 9 2023 09:00:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry

14 9 2023 09:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference

06 9 2023 16:10:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services

28 8 2023 05:30:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit

10 8 2023 16:05:02 提供 Nasdaq GlobeNewswire

Cytek Biosciences Reports Second Quarter 2023 Financial Results

08 8 2023 16:05:01 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023

20 7 2023 17:26:35 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference

31 5 2023 16:05:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Announces $50 Million Stock Repurchase Program

19 5 2023 09:00:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward

16 5 2023 08:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Reports First Quarter 2023 Financial Results

09 5 2023 16:05:03 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023

20 4 2023 16:05:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Introduces New 20-Color AML Panel

07 3 2023 17:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results

28 2 2023 16:05:01 提供 Nasdaq GlobeNewswire

Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed

28 2 2023 09:21:38 提供 Nasdaq GlobeNewswire

Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin

13 2 2023 16:07:03 提供 Nasdaq GlobeNewswire